Back
Verrica Pharmaceuticals Quote, Financials, Valuation and Earnings
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
17
VRCA
Verrica Pharmaceuticals
Last Price:
0.72
Seasonality Move:
31.35%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Verrica Pharmaceuticals Price Quote
$0.72
-0.03 (-3.52%)
(Updated: November 7, 2024 at 12:45 PM ET)
Verrica Pharmaceuticals Key Stats
Sell
17
Verrica Pharmaceuticals (VRCA)
is a Sell
Day range:
$0.74 - $0.87
52-week range:
$0.75 - $11.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.03
P/B ratio:
0%
Volume:
1.8M
Avg. volume:
1M
1-year change:
-80.26%
Market cap:
$34M
Revenue:
$5.1M
EPS:
$-1.84
How Much Does Verrica Pharmaceuticals Make?
-
How Much Are Verrica Pharmaceuticals's Sales Annually?
VRCA Revenues are $5.1M -
How Much Profit Does Verrica Pharmaceuticals's Make A Year?
VRCA net income is -$67M
Is Verrica Pharmaceuticals Growing As A Company?
Data Unavailable
Verrica Pharmaceuticals Stock Price Performance
-
Did Verrica Pharmaceuticals Stock Go Up Last Month?
Verrica Pharmaceuticals share price went down by -43.03% last month -
Did VRCA's Share Price Rise Over The Last Year?
VRCA share price fell by -80.26% over the past 1 year
What Is Verrica Pharmaceuticals 52-Week High & Low?
-
What Is Verrica Pharmaceuticals’s 52-Week High Share Price?
Verrica Pharmaceuticals has traded as high as $11.41 over the past 52 weeks -
What Is Verrica Pharmaceuticals’s 52-Week Low Share Price?
Verrica Pharmaceuticals has traded as low as $0.75 over the past 52 weeks
Verrica Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Verrica Pharmaceuticals?
-
How Much Debt Does Verrica Pharmaceuticals Have?
Total long term debt quarterly is $43.3M -
How Much Cash Does Verrica Pharmaceuticals Have?
Cash and short term investments quarterly total is $23M -
What Is Verrica Pharmaceuticals’s Book Value Per Share?
Book value per share is -0.80
Is Verrica Pharmaceuticals Cash Flow Positive?
-
What Is VRCA Cash Flow From Operations?
Cash flow from operations (TTM) is -$59.4M -
What Is Verrica Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.7M -
What Is Verrica Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$254K
Verrica Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
VRCA return on invested capital is -184.44% -
What Is Verrica Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -128.78% -
What Is VRCA Return On Equity?
ROE is a measure of profitability and is -2619.46%
Verrica Pharmaceuticals Earnings Date & Stock Price
-
What Is Verrica Pharmaceuticals's Stock Price Today?
A single share of VRCA can be purchased today for 0.75 -
What Is Verrica Pharmaceuticals’s Stock Symbol?
Verrica Pharmaceuticals trades on the nasdaq under the ticker symbol: VRCA -
When Is Verrica Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Verrica Pharmaceuticals is scheduled on November 8, 2024 -
When Is VRCA's next ex-dividend date?
Verrica Pharmaceuticals's next ex-dividend date is May 7, 2020 -
How To Buy Verrica Pharmaceuticals Stock?
You can buy Verrica Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Verrica Pharmaceuticals Competitors
-
Who Are Verrica Pharmaceuticals's Competitors?
Below is a list of companies who compete with Verrica Pharmaceuticals or are related in some way:
Verrica Pharmaceuticals Dividend Yield
-
What Is VRCA Dividend Yield?
Verrica Pharmaceuticals’s dividend yield currently is 0% -
What Is Verrica Pharmaceuticals’s Payout Ratio?
Verrica Pharmaceuticals’s payout ratio is 0% -
When Did Verrica Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 7, 2024 -
What Is Verrica Pharmaceuticals’s Dividend Per Share?
Verrica Pharmaceuticals pays a dividend of $0.00 per share
Verrica Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -26.45% |
| Revenue: | 0% | -133.85% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 9.50 |
| Upside from Last Price: | 1172.95% |